(Q30418715)

English

A cell culture-derived whole-virus H5N1 vaccine induces long-lasting cross-clade protective immunity in mice which is augmented by a homologous or heterologous booster vaccination

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

A cell culture-derived whole-virus H5N1 vaccine induces long-lasting cross-clade protective immunity in mice which is augmented by a homologous or heterologous booster vaccination (English)

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Otfried Kistner

7

object named as

Otfried Kistner

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

9

object named as

Thomas R Kreil

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Helga Savidis-Dacho

2

object named as

Helga Savidis-Dacho

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

8

object named as

P Noel Barrett

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

author name string

Nicolas Sabarth

1

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Michael G Schwendinger

3

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Peter Brühl

4

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Daniel Portsmouth

5

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Brian A Crowe

6

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

M Keith Howard

10

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

language of work or name

0 references

publication date

29 June 2012

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

30

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

37

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

5533-5540

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Avian influenza. Warning of H5N1 resurgence surprises community

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.043

7 January 2021

Effects of adjuvants on the safety and immunogenicity of an avian influenza H5N1 vaccine in adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.043

7 January 2021

A clinical trial of a whole-virus H5N1 vaccine derived from cell culture.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.043

7 January 2021

Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine: a randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.043

7 January 2021

Longevity of the protective immune response induced after vaccination with one or two doses of AS03A-adjuvanted split H5N1 vaccine in ferrets

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.043

7 January 2021

Pre-clinical development of cell culture (Vero)-derived H5N1 pandemic vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.043

7 January 2021

Cell culture (Vero) derived whole virus (H5N1) vaccine based on wild-type virus strain induces cross-protective immune responses.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.043

7 January 2021

A cell culture (Vero)-derived H5N1 whole-virus vaccine induces cross-reactive memory responses.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.043

7 January 2021

H5N1 whole-virus vaccine induces neutralizing antibodies in humans which are protective in a mouse passive transfer model

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.043

7 January 2021

Comparison of single, homologous prime-boost and heterologous prime-boost immunization strategies against H5N1 influenza virus in a mouse challenge model.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.043

7 January 2021

An improved single-radial-immunodiffusion technique for the assay of influenza haemagglutinin antigen: Application for potency determinations of inactivated whole virus and subunit vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.043

7 January 2021

Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.043

7 January 2021

Evaluation of the cellular immune responses induced by a non-adjuvanted inactivated whole virus A/H5N1/VN/1203 pandemic influenza vaccine in humans.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.043

7 January 2021

A pandemic influenza H1N1 live vaccine based on modified vaccinia Ankara is highly immunogenic and protects mice in active and passive immunizations

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.043

7 January 2021

Stockpiling prepandemic influenza vaccines: a new cornerstone of pandemic preparedness plans

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.043

7 January 2021

Pre- or post-pandemic influenza vaccine?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.043

7 January 2021

Cross-clade protective immune responses to influenza viruses with H5N1 HA and NA elicited by an influenza virus-like particle

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.043

7 January 2021

Immunization with reverse-genetics-produced H5N1 influenza vaccine protects ferrets against homologous and heterologous challenge.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.043

7 January 2021

H5N1 VLP vaccine induced protection in ferrets against lethal challenge with highly pathogenic H5N1 influenza viruses.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.043

7 January 2021

A vero cell-derived whole-virus H5N1 vaccine effectively induces neuraminidase-inhibiting antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.043

7 January 2021

A novel role for non-neutralizing antibodies against nucleoprotein in facilitating resistance to influenza virus.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.043

7 January 2021

Contributions of antinucleoprotein IgG to heterosubtypic immunity against influenza virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.043

7 January 2021

Influenza virus-like particles containing M2 induce broadly cross protective immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.043

7 January 2021

Development of adenoviral-vector-based pandemic influenza vaccine against antigenically distinct human H5N1 strains in mice.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.043

7 January 2021

Potent vesicular stomatitis virus-based avian influenza vaccines provide long-term sterilizing immunity against heterologous challenge.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.043

7 January 2021

Cationic liposome-DNA complexes (CLDC) adjuvant enhances the immunogenicity and cross-protective efficacy of a pre-pandemic influenza A H5N1 vaccine in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.043

7 January 2021

Influenza and the challenge for immunology

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.043

7 January 2021

T cell responses are better correlates of vaccine protection in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.043

7 January 2021

A whole virus pandemic influenza H1N1 vaccine is highly immunogenic and protective in active immunization and passive protection mouse models.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.043

7 January 2021

Superior immunogenicity of inactivated whole virus H5N1 influenza vaccine is primarily controlled by Toll-like receptor signalling.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.043

7 January 2021

Head-to-head comparison of four nonadjuvanted inactivated cell culture-derived influenza vaccines: effect of composition, spatial organization and immunization route on the immunogenicity in a murine challenge model

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.043

7 January 2021

Antibodies and B cell memory in viral immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.043

7 January 2021

Cytokines involved in B-cell differentiation and their sites of action

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.043

7 January 2021

Whole inactivated virus influenza vaccine is superior to subunit vaccine in inducing immune responses and secretion of proinflammatory cytokines by DCs.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.043

7 January 2021

Ab and T cell epitopes of influenza A virus, knowledge and opportunities

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.043

7 January 2021

Vaccinate before the next pandemic?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.043

7 January 2021

Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.043

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2012.06.043

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30418715&oldid=1972811511"